|
gptkb:Wonderland_protocol
|
staking rewards
|
|
gptkb:Glumetza_XR
|
decreases intestinal absorption of glucose
|
|
gptkb:idelalisib
|
PI3K delta inhibitor
|
|
gptkb:Enbucrilate
|
polymerizes on contact with blood
|
|
gptkb:HLX04_(bevacizumab_biosimilar)
|
VEGF inhibitor
|
|
gptkb:isoflurane
|
inhibits neuronal ion channels
|
|
gptkb:Oxymorphone
|
mu-opioid receptor agonist
|
|
gptkb:The_Writer_automaton
|
clockwork
|
|
gptkb:BCL2_family_proteins
|
protein-protein interactions
|
|
gptkb:Sumatriptan
|
5-HT1B/1D receptor agonist
|
|
gptkb:Cosopt
|
reduces intraocular pressure
|
|
gptkb:metformin
|
decreases hepatic glucose production
|
|
gptkb:Trastuzumab
|
inhibits proliferation of HER2-overexpressing cells
|
|
gptkb:Genetic_Use_Restriction_Technology
|
genetic modification to produce sterile seeds
|
|
gptkb:Corticosteroid
|
binds to mineralocorticoid receptor
|
|
gptkb:parsaclisib
|
gptkb:PI3Kδ_inhibitor
|
|
gptkb:Cry1F_delta-endotoxin
|
pore formation in insect gut
|
|
gptkb:Vacuum_Circuit_Breaker
|
Magnetic Actuator
|
|
gptkb:Rivastigminum
|
inhibits acetylcholinesterase and butyrylcholinesterase
|
|
gptkb:alitretinoin
|
retinoic acid receptor agonist
|